Jazz Pharmaceuticals Files 8-K on Financials
Ticker: JAZZ · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Jazz Pharma dropped an 8-K on Feb 25th detailing their financials. Check it out.
AI Summary
Jazz Pharmaceuticals plc filed an 8-K on February 25, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Dublin, Ireland.
Why It Matters
This filing provides investors with updated information on Jazz Pharmaceuticals' financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no immediate negative or positive news.
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Registrant
- February 25, 2025 (date) — Date of Report
- Dublin, Ireland (location) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on February 25, 2025.
Where are Jazz Pharmaceuticals' principal executive offices located?
The principal executive offices are located at Fifth Floor, Waterloo Exchange, Waterloo Road, Dublin 4, Ireland.
What is the SEC Act under which this report is filed?
This report is filed pursuant to the 1934 Act.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number for Jazz Pharmaceuticals plc is 98-1032470.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding Jazz Pharmaceuticals plc (JAZZ).